What’s New in the CTN?
Updates from the NIDA National Drug Abuse Treatment Clinical Trials Network. Want to share some news about your protocol, node, publications or presentations, or other CTN-related work here and/or in the CTN Bulletin? Email us at ctnlib@uw.edu!
Prenatal Action for Taking Healthy Steps (PATHS) Toolkit: Spanish Materials Now Available!
The Prenatal Action for Taking Healthy Steps (PATHS) toolkit, developed out of protocol CTN-0080-A3 (led by the Ohio Valley Node), offers evidence-based educational resources about the use of medication to treat opioid use disorder (OUD) during and after pregnancy. The collection of resources was already available in two formats: one for general English speakers and another version adapted to be culturally and linguistically appropriate for American Indians & Alaska Natives. Now, added just last week, materials are now also available in Spanish! Resources include: Check out the complete PATHS Toolkit here!…
Submit Your Paper for the CTN 25th Anniversary Special Issue of JSAT!
To commemorate the 25th anniversary of the Clinical Trials Network, a special issue of the Journal of Substance Use and Addiction Treatment (JSAT) is being developed to highlight the remarkable contributions made across the network over the past 25 years. The journal is currently accepting submissions in the following categories: Interested in contributing? Please contact Mitchell Garets, MSW, at mitchell.garets@hsc.utah.edu from the Greater Intermountain Node for submission guidelines or any questions. While submissions will be accepted through Fall 2025, we encourage early contributions to support planning and review.
News from the Western States Node: Webinar on CTN-0108 (TMS for Stimulant Use Disorder), June 25, 2025 (11am PT)
Join the CTN Western States Node, Northwest ATTC, and Pacific Southwest ATTC for their next joint webinar: CTN-0108: Transcranial Magnetic Stimulation in the Treatment of Stimulant Use Disorder (June 25, 2025, 11am-12:30pm PT). 1.5 CME/CE credits available. Accreditation information. In this session, Kathleen T. Brady, MD, PhD, of the Medical University of South Carolina, will discuss the NIDA N Clinical Trials Network (CTN) study CTN-0108, “Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder,” a pilot study that aims to determine the feasibility, effectiveness, and safety for 20 sessions…
News from the Northeast Node: Science Series Webinar on Digital Tools, June 12, 2025 (12pm ET)
1.0 CME, ANCC, or Vermont OPR CE credits available! Advances in digital technology, such as mobile devices, have fundamentally changed our society and are rapidly changing how we provide substance use and mental healthcare. In this webinar from the CTN Northeast Node, part of their ongoing Science Series, Dr. Lisa Marsch, Director of the Dartmouth Center for Technology and Behavioral Health, will discuss how digital technology can provide state-of-the science, personalized behavioral healthcare anytime and anywhere. She will review how data collected from mobile devices can provide new insights into…
CTN Community Representation Council Meeting Summary (April 2025)
The National Drug Abuse Treatment Clinical Trials Network Community Representative Council (CTN CIRCL) is a collaborative of the national CTN that comes together bi-monthly to courageously share what’s happening in their communities. This summary provides an overview of topics discussed at the April 2025 meeting and is not an exhaustive review. The thoughts and experiences herein are those of CIRCL members and do not represent the National Institute on Drug Abuse or the Clinical Trials Network. The voices empowered by CIRCL are intended to drive research and clinical efforts in…
CTN Primary Care SIG: Methadone in Primary Care (May 19, 2025, 12pm ET)
The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices. Primary Care SIG Key Objectives Primary Care SIG Webinars and presentations The Primary Care SIG is led by Sebastian Tong, MD, MPH, and meets every other month on the 4th Monday of the month from 9-10am PT/12-1pm ET. To join the Primary Care SIG webinar series listserv, please provide your contact information here. Next Primary Care…
News from the Greater Intermountain Node: Podcast & SUPeRAD Expansion
Let’s Talk About Drugs in the Intermountain West Podcast The Greater Intermountain Node is housed within the Program of Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) at the University of Utah. As part of its outreach and advocacy efforts, PARCKA produces a weekly podcast, Let’s Talk About Drugs in the Intermountain West. New episodes are released every Wednesday, featuring conversations that explore topics around addiction and spotlight the efforts being made to address substance use disorders across the Greater Intermountain West. This May marks the podcast’s one-year anniversary! You…
CTN T&I SIG: CTN T&I SIG: Implementation of ED-Initiated Buprenorphine for Opioid Use Disorder (May 20, 2025, 9am PT)
Join the CTN Translation & Implementation (T&I) SIG on May 20, 2025 (9-10am PT) for their next virtual meeting, featuring the work of CTN-0069: Opioid Use Disorder in the Emergency Department (Project ED Health). Presenters Gail D’Onofrio, MD, MS, and David A. Fiellin, MD, will share their study approach and results, as well as considerations for integrating implementation outcome evaluations in efficacy/effectiveness protocols. Read more about the session and presenters here (pdf)! Interested in attending? Reach out to Elena Rosenberg-Carlson (rosenbee@stanford.edu) for the meeting link and/or to join the SIG…
News from the New York Node: NIDA Lifetime Achievement Award for Dr. John Rotrosen
The New York Node is proud to announce that Dr. John Rotrosen, MD, an esteemed and long-time member of the CTN, has been presented the Lifetime Achievement Award by the National Institute on Drug Abuse (NIDA), in recognition of his unwavering commitment to the advancement of translational research in the area of substance use and other psychiatric disorders. This distinguished honor recognizes his outstanding contributions advancing science that improves lives. Dr. Rotrosen’s contributions to addiction, ADHD, schizophrenia, and movement disorders research have made a significant impact on public health, including…
News from the Ohio Valley Node: Summer Speaker Series (Webinars)
The Center for Addiction Research at University of Cincinnati, part of the Ohio Valley Node (OVN), is hosting a Summer Speaker Series hosted by T. John Winhusen, PhD, PI of the OVN. June 11, 2025, 12-1pm ETForming an Interprofessional Workforce to Address Opioid Use Disorder Among At-Risk Youth Presenters: Michael D. Brubaker, PhD, LICDC-CS, NCC (U. Cincinnati) and Kaycia Spenser, LISW (Cincinnati Children’s Hospital).Register for the June session July 9, 2025, 12-1pm ETEndocannabinoid Regulation of Repeated Stress-Cocaine Interactions Presenter: Jayme McReynolds, PhD (University of Cincinnati)Register for the July session August…
New in the Library (April – May 2025)
Here are the latest items added to the CTN Dissemination Library for April – May 2025 (this post will be updated as new items come in): Impact of Recent Stimulant Use on Treatment Outcomes Amongst Individuals Initiating Medications for Opioid Use Disorders: Secondary Analysis of a Multisite Randomized Controlled Trial. Coles C, et al. Drug and Alcohol Dependence Reports 2025;15:100330. (CTN-0027) Exploring the Impact of Reduction in Methamphetamine Use on Sexual Risk Behaviors Among Men Who Have Sex with Men and Women: Findings from the ADAPT- 2 Trial. Okafor CN,…
News from the New York Node
From our CTN-0139 Lead team: The CTN-0139 Lead Team is thrilled to announce that all study sites are now endorsed for patient recruitment! Congratulations to all teams for this important accomplishment! There are currently 128 PCP participants, and 28 patient participants enrolled. Thank you to all the teams who have been working so hard; we look forward to continued progress on the study!
News from the Pacific Northwest Node
Congratulations to Judith Tsui, MD, MPH, member of the CTN Pacific Northwest Node, who has just been named the President-Elect of CPDD (College on Problems of Drug Dependence)! Dr. Tsui is a Professor of Medicine at the University of Washington, based at Harborview Medical Center and Evergreen Treatment Services, Director of the UW GIM Substance Use Research and Education (SURE) Unit, Associate Director of the Addiction Medicine Fellowship at the UW, Director of the UW/Fred Hutch Center for AIDS Research Substance Scientific Working Group, and PI/Director of the NIH/NIDA R25-funded…
Recording available! CTN Youth SIG Webinar: Implications of Basic Emotion Science for SUD Treatment & Intervention
The CTN Youth SIG hosted the following webinar in March 2025: Implications of basic emotion science for substance use treatment and intervention Presenter: Michelle “Lani” Shiota, Ph.D.Professor, Department of PsychologyDirector, Substance use and Addiction Translational Research Network (SATRN)Arizona State University Dr. Michelle “Lani” Shiota is a Professor of Psychology at ASU conducting research on positive emotions, emotion regulation, and emotion-related mechanisms of health behavior. As Director of SATRN@ASU she guides a network of academic researchers and community partners in promoting community-engaged and interdisciplinary addiction science as well as evidence-based practice….
CTN Library Site May Be Unavailable April 8-9, 2025
The CTN Library website will be undergoing some server upgrades starting in the afternoon of Tuesday, April 8th and may be temporarily unavailable throughout the evening and into the next day. If you have an urgent need for any information or publications from the site, please contact ctnlib@uw.edu for assistance! Posted on April 7, 2025.
New CTN SIG: Secondary Data Analysis
We would like to announce the creation of a new Special Interest Group and extend an invitation to all who are interested in participating. The CTN Secondary Data Analysis SIG’s mission is to maximize the scientific knowledge gleaned from each CTN study conducted by standardizing, promoting, and supporting the use of existing CTN data to answer novel research questions. We discuss how to make data access and navigation easier, procedures and best practices for conducting secondary data analyses, and what research questions available data may be able to answer. Please…
Learning for Early Careers in Addiction & Diversity (LEAD Program): Apply by April 15, 2025!
The Learning for Early Careers in Addiction and Diversity (LEAD) program offers mentorship and training to postdoctoral fellows and assistant professors who are pursuing independent research careers in substance use and substance use disorder treatment. This support is aimed at individuals from racial and ethnic minoritized groups who are underrepresented among NIH-funded investigators in this field. The LEAD Program uses the NIDA Clinical Trials Network (CTN) as a platform for training early-careerinvestigators. This 3-year training program is based at the University of California, San Francisco (UCSF), and visiting scholars spend…
Fellowship in Addiction Dissemination & Implementation Science – Deadline extended to APRIL 15!
Applications are now being accepted for the 2025–2026 Center for Dissemination and Implementation At Stanford (C-DIAS) Fellowship in Addiction Dissemination & Implementation (D&I) Science. The C-DIAS Fellowship in Addiction Dissemination & Implementation (D&I) Science is for early or mid-career individuals with goals to improve public access to and quality of addiction treatment by leveraging advanced implementation science methods. Submit your application by April 15th, 2025. This year-long mentored learning experience: Activities include monthly, virtual, hour-long lectures; participation in the C-DIAS Research Core sections activities; C-DIAS Virtual Grand Rounds; individualized mentoring; lead…
News from the Appalachian Node: Updates from the CTN-0139 Co-CARE study
Jane Liebschutz (Appalachian Node), Rebecca Stone (NY Node) and Donna Beers (Boston Medical Center) traveled to Enterprise OR to conduct a site visit at Winding Waters, a federally qualified health center participating in CTN 139-CoCare. The three city slickers enjoyed their first taste of Frontier designation, which is less than 6 people per square mile. The view was stunning with snow capped peaks and a gorgeous river. But what impressed us all was the dedication and smooth running of the clinic. The five physicians and three physician assistants provide primary care, mental health…
Primary Care SIG Meeting: March 24, 2025 (9-10am PT/12-1pm ET)
The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices. Primary Care SIG Key Objectives Primary Care SIG Webinars and presentations The Primary Care SIG is led by Joe LeMaster, MD, MPH and Sebastian Tong, MD, MPH, and meets every other month on the 4th Monday of the month from 9-10am PT/12-1pm ET. To join the Primary Care SIG webinar series listserv, please provide your contact…